SERUM CLONAZEPAM TOXICOLOGY CONTROL— 510(k) K862421

Substantially Equivalent

Utak Laboratories, Inc.

FDA 510(k) clearance K862421 for SERUM CLONAZEPAM TOXICOLOGY CONTROL, Substantially Equivalent on 1986-11-05. Applicant: Utak Laboratories, Inc..

Clearance details

Applicant
Utak Laboratories, Inc.
Product code
Code LAS
Advisory panel
Clinical Toxicology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Canyon Country, CA, US
Download summary PDFView on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.